sb.scorecardresearch
Advertisement

Published 09:26 IST, March 8th 2024

US FDA grants expanded approval for BeiGene's blood cancer drug

According to BeiGene, the US wholesale acquisition cost for Brukinsa stands at $15,066 for a 30-day supply, with consistent pricing across all indicated uses.

Reported by: Business Desk
Follow: Google News Icon
  • share
Cancer drug
Cancer drug | Image: Unsplash
Advertisement

09:26 IST, March 8th 2024